Clinical Perspectives of Theranostics

Clinical Perspectives of Theranostics

Theranostics is a precision medicine which integrates diagnostic nuclear medicine and radionuclide therapy for various cancers throughout body using suitable tracers and treatment that target specific biological pathways or receptors. This review covers traditional theranostics for thyroid cancer an...

Full description

Bibliographic Details
Main Authors:	Shozo Okamoto, Tohru Shiga, Nagara Tamaki
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Molecules
Subjects:	PET theranostics radionuclide therapy cancer prognosis
Online Access:	https://www.mdpi.com/1420-3049/26/8/2232

Similar Items

It is time to move forward into the era of Theranostics
by: Hojjat Ahmadzadehfar, et al.
Published: (2018-01-01)

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
by: Thomas S. C. Ng, et al.
Published: (2021-07-01)

Theranostic SPECT reconstruction for improved resolution: application to radionuclide therapy dosimetry
by: H. Marquis, et al.
Published: (2021-02-01)

Editorial: Nuclear Medicine in the Context of Personalized Medicine
by: Jacques Barbet, et al.
Published: (2020-06-01)

Copper-64: a real theranostic agent
by: Gutfilen B, et al.
Published: (2018-10-01)

Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow
by: Vladimir B. Sergienko, et al.
Published: (2021-04-01)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
by: Gloria Bertoli, et al.
Published: (2016-03-01)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
by: Rou Li, et al.
Published: (2021-01-01)

Nuclear Medicine in the Context of Personalized Medicine
Published: (2020)

Biomarkers in Prostate-Specific Membrane Antigen Theranostics
by: Panagiotis J. Vlachostergios, et al.
Published: (2021-06-01)

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy
by: Sofia Koustoulidou, et al.
Published: (2021-03-01)

The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
by: Alex J. Poot, et al.
Published: (2020-11-01)

Radiolabeled theranostics: magnetic and gold nanoparticles
by: Saeideh Same, et al.
Published: (2016-09-01)

Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers
by: Zhuoran Gong, et al.
Published: (2021-05-01)

Ovarian Cancer Targeted Theranostics
by: Sridhar Nimmagadda, et al.
Published: (2020-01-01)

Smart Multifunctional Theranostics: Simultaneous Diagnosis and Therapy of Cancer
by: Yadollah Omidi
Published: (2011-09-01)

Recent progress of nanotechnology-based theranostic systems in cancer treatments
by: Ying Xue, et al.
Published: (2021-05-01)

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
by: Mohamed El Fakiri, et al.
Published: (2021-08-01)

Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer
by: Anubhab Mukherjee, et al.
Published: (2019-04-01)

Theranostic Advances in Breast Cancer in Nuclear Medicine
by: Nasim Vahidfar, et al.
Published: (2021-04-01)

Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study
by: Courtney Lawhn-Heath, et al.
Published: (2020-10-01)

Theranostics: A treasured tailor for tomorrow
by: S Jeelani, et al.
Published: (2014-01-01)

IR820 Nanoconjugates for Theranostic Applications
by: Fernandez-Fernandez, Alicia
Published: (2013)

Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
by: Lisa Bartmann, et al.
Published: (2019-02-01)

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
by: Michiel Van de Voorde, et al.
Published: (2021-07-01)

Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
by: Lisa Bartmann, et al.
Published: (2020-11-01)

Chemodynamic nanomaterials for cancer theranostics
by: Jingqi Xin, et al.
Published: (2021-06-01)

The future of Extracellular Vesicles as Theranostics – an ISEV meeting report
by: Carolina Soekmadji, et al.
Published: (2020-01-01)

Theranosticsin nuclear medicine and oncology
by: Sergio Baldari, et al.
Published: (2019-04-01)

188Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy
by: Alessandra Boschi, et al.
Published: (2017-01-01)

Innovative Radiopharmaceuticals in Oncology and Neurology
Published: (2017)

Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
by: Jörgen Elgqvist
Published: (2017-05-01)

Current Perspectives on Clinical Use of Exosomes as a Personalized Contrast Media and Theranostics
by: Tomasz Lorenc, et al.
Published: (2020-11-01)

Photodynamic Therapy Based on Graphene and MXene in Cancer Theranostics
by: Arianna Gazzi, et al.
Published: (2019-10-01)

Theranostic nanomedicine for cancer detection and treatment
by: Zhen Fan, et al.
Published: (2014-03-01)

Subcellular Targeting of Theranostic Radionuclides
by: Bas M. Bavelaar, et al.
Published: (2018-09-01)

Chapter Pretargeted Theranostics
Published: (2021)

Chapter Pretargeted Theranostics
by: Markus, Staudt
Published: (2021)

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
by: Sudath Hapuarachchige, et al.
Published: (2020-07-01)

A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy
by: Jing Hao Fan, et al.
Published: (2019-12-01)